Drug recall · December 8, 2021
Tydemy (drospirenone recall
Why: Subpotent Drug
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Tydemy (drospirenone, ethinyl estradiol & levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium tablets, 0.451 mg), packaged in cartons containing 3 wallets of 28 Tablets each, Rx Only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United Stated, Manufactured by: Lupin Limited, Pithampur, (M.P.) - 454775, India, 244896, The individual wallet NDC 68180-904-11 and the carton NDC 68180-904-13.
- Lots / codes
Lot #: L000784 and L000785, Exp. Date May 2022
- Quantity
- 4113 cartons
- Company
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Distribution
- nationwide within the United States
- Initiated
- November 19, 2021 · Voluntary: Firm initiated
- Classified
- December 1, 2021
- Reported
- December 8, 2021
- Ended
- November 15, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Drospirenone / ethinyl estradiol / levomefolate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.